CDSCO
- Hyderabad
Hyderabad: Biphore, Zenara get CDSCO approval for neuro disorder drug
Hyderabad: Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control Organisation (CDSCO) for manufacturing and marketing of Cannabidiol active ingredient in India. Its subsidiary,…
- India
Over 3 percent of 84,874 drug samples tested in 2020-21 were found substandard: Govt
New Delhi: More than three percent of the 84,874 drug samples tested in 2020-21 were declared not of standard quality and 263 of them were found to be spurious and adulterated, Minister…
- India
CDSCO approved recombinant nasal Covid vaccine on Sep 5: Govt in Rajya Sabha
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) approved the recombinant nasal COVID-19 vaccine on September 5 this year for those aged 18 years and above, Minister of State for Health…
- India
CDSCO launches probe after WHO issues alert on four Indian cough syrups
New Delhi: After World Health Organization (WHO) on Wednesday issued an alert on four India-made cough and cold syrups ‘potentially linked with acute kidney injuries and 66 deaths among children in Gambia’,…
- Health
BE gets approval to manufacture pediatric vaccine for S. pneumonia
Hyderabad: Vaccine manufacturer Biological E. Limited (BE) announced on Thursday that the Subject Expert Committee of Central Drugs Standard Control Organization (CDSCO) has approved the Phase 3 infants clinical trial data and…
- India
India’s precautionary COVID-19 doses not approved by CDSCO
The precautionary doses of COVID-19 vaccines rolled out by PM Modi on January 10, 2022, were not approved by the Central Drug Standards Control Organisation (CDSCO). The nodal drug agency of the…
